Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

Published

20% of all subjects that completed the 24-week treatment period achieved SALT ≤ 20

29% of completed subjects with moderate to severe disease (baseline SALT 35 to

In This Story

EQ